The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV‐077 is a more potent inhibitor of platelet function than aspirin
Pierre Fontana(Université de Montpellier), Alexandra Santana Sorensen(Evolva (Switzerland)), Henri Bounameaux(University of Geneva), Pēteris Alberts(Maxygen (United States)), Jon‐Paul Meyer(Churchill Hospital), Kjell S. Sakaríassen(Ospedale degli Infermi)
Cited by 18
Related Papers
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2003|809
Thalassemia Syndromes
|Unknown|2009|475
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263